Canopy Growth (CGC) Operating Income (2019 - 2025)

Canopy Growth (CGC) reported Operating Income of -$47.2 million for Q4 2025, down 176.98% on a YoY basis from $61.4 million in Q4 2024, and down 284.77% sequentially from -$12.3 million in Q3 2025.

Canopy Growth (CGC) Operating Income (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Operating Income data on file, last reported at -$47.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Income fell 176.98% year-over-year to -$47.2 million; the trailing twelve-month figure through Dec 2025 stood at -$92.9 million (up 38.58% YoY), and the FY2026 full-year result was -$117.9 million, down 44.4% from the prior year.
  • Operating Income eased to -$47.2 million in Q4 2025, from -$12.3 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$5.2 million in Q3 2023 to a low of -$1.4 billion in Q2 2022.
  • A 5-year average of -$176.7 million and a median of -$79.2 million in 2024 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income plunged 846.31% in 2022 and jumped 97.18% in 2023, its largest moves.
  • Tracing CGC's Operating Income over 5 years: stood at -$119.0 million in 2021, then jumped by 30.22% to -$83.0 million in 2022, then surged by 46.63% to -$44.3 million in 2023, then soared by 61.51% to -$17.1 million in 2024, then tumbled by 176.98% to -$47.2 million in 2025.
  • Business Quant data shows CGC's Operating Income at -$47.2 million in Q4 2025, -$12.3 million in Q3 2025, and -$16.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -47.23 Mn
Sep 30, 2025 -12.28 Mn
Jun 30, 2025 -16.33 Mn
Dec 31, 2024 -17.05 Mn
Sep 30, 2024 -33.68 Mn
Jun 30, 2024 -21.28 Mn
Mar 31, 2024 -79.21 Mn
Dec 31, 2023 -44.30 Mn
Sep 30, 2023 -5.23 Mn
Jun 30, 2023 -40.69 Mn
Mar 31, 2023 -402.97 Mn
Dec 31, 2022 -83.02 Mn
Sep 30, 2022 -114.38 Mn
Jun 30, 2022 -1.45 Bn
Mar 31, 2022 -367.71 Mn
Dec 31, 2021 -118.97 Mn
Sep 30, 2021 -171.08 Mn
Jun 30, 2021 -152.71 Mn
Mar 31, 2021 -184.25 Mn
Dec 31, 2020 -424.65 Mn